Hinge Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	587.86	390.4	292.73
Revenue Growth (YoY)	50.58%	33.37%	-
Cost of Revenue	118.56	89.81	98.55
Gross Profit	469.3	300.59	194.18
Selling, General & Admin	646.46	230.97	214.64
Research & Development	368.14	100.84	110.06
Other Operating Expenses	1.08	-	-
Operating Expenses	1,016	331.81	324.69
Operating Income	-546.37	-31.22	-130.51
Interest & Investment Income	18.68	20.57	21.7
Other Non Operating Income (Expenses)	0.43	0.08	0.27
EBT Excluding Unusual Items	-527.26	-10.57	-108.55
Merger & Restructuring Charges	-	-0.69	-
Pretax Income	-527.26	-11.26	-108.55
Income Tax Expense	1	0.68	-0.41
Net Income	-528.26	-11.93	-108.14
Preferred Dividends & Other Adjustments	-104.17	-	-
Net Income to Common	-424.09	-11.93	-108.14
Shares Outstanding (Basic)	55	14	13
Shares Outstanding (Diluted)	55	14	13
Shares Change (YoY)	302.55%	4.16%	-
EPS (Basic)	-7.77	-0.88	-8.31
EPS (Diluted)	-7.77	-0.88	-8.31
Free Cash Flow	170.73	47.96	-65.89
Free Cash Flow Per Share	3.13	3.54	-5.06
Gross Margin	79.83%	77.00%	66.33%
Operating Margin	-92.94%	-8.00%	-44.59%
Profit Margin	-72.14%	-3.06%	-36.94%
Free Cash Flow Margin	29.04%	12.29%	-22.51%
EBITDA	-544.24	-28.87	-128.39
EBITDA Margin	-92.58%	-7.40%	-43.86%
D&A For EBITDA	2.13	2.35	2.13
EBIT	-546.37	-31.22	-130.51
EBIT Margin	-92.94%	-8.00%	-44.59%
Advertising Expenses	53.6	37.3	23.8

Source: S&P Capital IQ. Standard template. Financial Sources.